Andrews Paul 4
4 · MONARCH CASINO & RESORT INC · Filed Feb 12, 2026
Research Summary
AI-generated summary of this filing
Monarch Casino (MCRI) Director Paul Andrews Sells 6,100 Shares
What Happened
Paul Andrews, a director of Monarch Casino & Resort, sold a total of 6,100 shares reported as derivative dispositions on February 9, 2026. The filings show two sales at $97.40 per share: 3,000 shares for $292,200 and 3,100 shares for $301,940, for combined proceeds of $594,140. These were reported as open market or private sales (transaction code S). This is a sale (not a purchase), which is often routine insider selling and does not by itself indicate company performance.
Key Details
- Transaction date and price: Feb 9, 2026 — 3,000 shares @ $97.40 ($292,200) and 3,100 shares @ $97.40 ($301,940).
- Total shares sold: 6,100; total proceeds: $594,140.
- Shares owned after transaction: Not specified in the provided summary — check the full Form 4 for post-transaction beneficial ownership.
- Footnotes/plan details: The summarized data lists these as "Derivative" dispositions; no 10b5‑1 plan, tax-withholding, or other footnotes were indicated in the provided summary. Review the filing for any additional notes.
- Filing timeliness: Form 4 was filed on Feb 12, 2026 (trade date Feb 9) — three days after the trade; this may be later than the typical two-business-day Form 4 deadline.
Context
"Derivative" in the filing means the shares disposed originated from derivative holdings (for example, option-related shares or other derivative instruments) rather than a simple open‑market stock purchase; consult the Form 4 for exact instrument details. For retail investors, purchases by insiders can be a stronger signal than sales; sales are common for liquidity or tax reasons and should be viewed alongside other filings and company news.
Insider Transaction Report
- Sale
Options / Right to Buy
2026-02-09$97.40/sh−3,000$292,200→ 54,900 totalExercise: $21.85From: 2016-12-08Exp: 2026-06-08→ Common Stock (3,000 underlying) - Sale
Options / Right to Buy
2026-02-09$97.40/sh−3,100$301,940→ 51,800 totalExercise: $31.23From: 2017-12-14Exp: 2027-06-14→ Common Stock (3,100 underlying)
- 5,000
Common Stock
- 51,800
Options / Right to Buy
Exercise: $86.44From: 2025-12-31Exp: 2035-06-30→ Common Stock (6,100 underlying) - 51,800
Options / Right to Buy
Exercise: $68.13From: 2024-12-31Exp: 2034-06-30→ Common Stock (6,100 underlying) - 51,800
Options / Right to Buy
Exercise: $70.45From: 2023-12-31Exp: 2033-06-30→ Common Stock (6,100 underlying) - 51,800
Options / Right to Buy
Exercise: $58.67From: 2022-12-31Exp: 2032-06-30→ Common Stock (6,100 underlying) - 51,800
Options / Right to Buy
Exercise: $66.17From: 2021-12-31Exp: 2031-06-30→ Common Stock (6,100 underlying) - 51,800
Options / Right to Buy
Exercise: $44.60From: 2021-03-31Exp: 2030-09-30→ Common Stock (6,100 underlying) - 51,800
Options / Right to Buy
Exercise: $43.09From: 2019-12-04Exp: 2029-06-04→ Common Stock (6,100 underlying) - 51,800
Options / Right to Buy
Exercise: $44.55From: 2019-12-12Exp: 2028-06-12→ Common Stock (6,100 underlying) - 51,800
Options / Right to Buy
Exercise: $31.23From: 2017-12-14Exp: 2027-06-14→ Common Stock (3,000 underlying)